Appointment deepens scientific leadership as Decoy advances its Designable Multi-Antiviral pipeline toward clinical development NEW YORK and CAMBRIDGE, Mass., May 26, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a clinical-stage biotechnology company pioneering a new...
Hence then, the article about decoy therapeutics names brad pentelute mit professor of chemistry as chair of scientific advisory board was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board )
Also on site :
- ‘The Debut’ Review: Julianne Moore Is Astonishing in Jesse Eisenberg’s Funny and Dizzying Community-Theater Comedy
- 1981 No. 1 Hit, Written by Hank Williams Jr., Is Still an Iconic Salute to Wilder Days 45 Years Later
- The Pioneer Woman’s ‘Darling’ Scalloped Ramekins Are Just $5 and Perfect for Snacks, Dips, and Desserts